Browse regulations

Regulations governing mortgage insurance for healthcare facilities under Section 232 of the National Housing Act, covering eligibility requirements, fire safety equipment standards, loan terms, and insurance premium calculations.

These regulations create unnecessary federal bureaucracy in healthcare facility financing, impose costly compliance burdens on small providers, and federalize functions that should be handled by states and private markets. The extensive rules on bathroom requirements, debt service reserves, and insurance premium structures distort healthcare markets and raise costs for vulnerable populations.

This regulation cross-references 24 CFR part 207, subpart B, applying its requirements to mortgages insured under section 231 of the National Housing Act. All references to 'section 207' in part 207 are construed as 'section 231' for these multifamily project mortgages.

Deleting this cross-reference would create regulatory uncertainty by obscuring which rules apply to section 231 mortgages, potentially leading to noncompliance or litigation. It achieves clarity efficiently through a simple incorporation by reference mechanism. The real regulatory burden resides in part 207, subpart B itself, not in this organizational provision.

Federal Housing Administration regulations governing multifamily project mortgages under Section 221 of the National Housing Act, including insurance provisions, assignment options, forbearance agreements, and relocation assistance requirements.

These regulations represent federal overreach into housing markets, creating moral hazard by guaranteeing mortgages, distorting market pricing, and imposing costly compliance burdens that ultimately raise housing costs for all Americans while protecting politically connected interests.

This regulation establishes insurance provisions for mortgages covering 1- to 11-family dwellings under section 220 of the National Housing Act, including premium calculations, default procedures, and claim processes similar to section 203 mortgages but with specific modifications for this program.

Creates a costly federal insurance program that distorts housing markets, encourages excessive risk-taking by lenders, and imposes compliance burdens on the financial sector while providing questionable benefits to homeowners.

Multifamily housing mortgage insurance program under section 213 of the National Housing Act, establishing eligibility requirements, premium structures, contract rights, and obligations for cooperative and investor-sponsored housing projects, with specific provisions for supplementary loans, operating loss loans, and the Cooperative Management Housing Insurance Fund.

Federal housing subsidies distort market pricing, create moral hazard, and disproportionately benefit politically connected developers while inflating housing costs. The program's complex premium structures and insurance mechanisms create hidden taxpayer liabilities and bureaucratic overhead that would be eliminated by market-based financing.

This regulation governs mortgage insurance for multifamily housing projects, establishing eligibility requirements, premium structures, default procedures, and insurance claim processes for mortgages insured under section 207 of the National Housing Act.

This federal housing regulation creates a complex bureaucratic system that distorts free market housing development, imposes hidden costs through insurance premiums, and expands federal control over local housing markets beyond constitutional limits.

Regulation establishes three FHA mortgage underwriting procedures: Direct Endorsement (lender underwrites with HUD post-review), Lender Insurance (self-insuring with performance thresholds), and HUD office processing. Sets eligibility requirements including 5-year experience, underwriter registration, sample mortgage submissions, and ongoing claim/default rate monitoring with sanctions and termination processes.

Imposes disproportionate compliance costs on small lenders through experience thresholds and bureaucratic oversight, raises barriers to entry protecting incumbents, and represents unjustified federal micromanagement of private underwriting that distorts market competition and increases borrowing costs.

This regulation governs FHA mortgage insurance requirements for multifamily and other housing projects, including mortgagor eligibility, fee structures, application processes, compliance standards, and various program-specific provisions under the National Housing Act. It establishes detailed rules for obtaining federal mortgage insurance, which subsidizes and reduces risk for lenders and developers.

FHA mortgage insurance exceeds constitutional authority under the Tenth Amendment, distorts market pricing of risk through moral hazard, imposes $ billions in compliance costs that raise housing prices, and crowds out private mortgage insurance alternatives. This federal intervention into voluntary private transactions represents illegitimate government overreach that violates core principles of limited government and free enterprise. The unseen costs—including malinvestment, inflated asset prices, and barriers to entry for smaller developers unable to navigate the regulatory labyrinth—far outweigh any purported benefits.

This regulation mandates accessibility standards for publicly owned residential structures to ensure physically handicapped persons have ready access and use of such buildings, covering structures constructed, leased, or financed by the federal government after August 12, 1968.

Americans would be worse off if this regulation was deleted because it ensures basic accessibility for disabled individuals in publicly owned housing, preventing discrimination and enabling independent living for millions of Americans who would otherwise face severe mobility barriers in federally funded or operated residential structures.

Federal Tort Claims Act procedures for Department of Housing and Urban Development claims, including personal injury, death, property damage, and employee property loss claims with specific filing requirements and compensation limits.

This regulation provides essential legal procedures for citizens to seek compensation from the federal government for injuries or losses caused by government employees. Without it, Americans would have no legal recourse against federal negligence, creating an unaccountable government that could harm citizens without consequence.

This regulation governs DEA administrative inspection and hearing procedures under the Controlled Substances Act. It defines terms, outlines inspection authority and warrant requirements, protects certain data from disclosure, establishes research confidentiality/exemption processes, and sets hearing protocols.

These procedural safeguards protect Fourth Amendment rights and due process, preventing arbitrary searches and ensuring rule of law. Deleting them would increase government overreach and uncertainty for legitimate businesses, even if the underlying Controlled Substances Act itself is constitutionally questionable. The regulations achieve necessary constraints on enforcement in a clear, predictable manner that is superior to ad hoc case-by-case determinations.

Regulates importation, exportation, transshipment and intransit shipment of controlled substances, requiring permits/declarations, registration, documentation, and compliance with international conventions for narcotics and psychotropic substances.

Creates massive regulatory burden on legitimate medical/scientific trade while failing to stop black market drug flows. $2 trillion compliance costs, constitutional overreach into interstate commerce, and bureaucratic red tape that protects established players from competition.

DEA regulations implementing the Controlled Substances Act, covering practitioner registration, distribution limits (5% cap), record-keeping requirements, incidental manufacturing exemptions, emergency transfers between hospitals/EMS, religious peyote exemption, and temporary telemedicine prescribing authority through December 31, 2026.

This regulation enforces an unconstitutional federal overreach into state police powers under the Tenth Amendment. The arbitrary 5% distribution limit distorts healthcare delivery and imposes crushing compliance costs that disproportionately burden small medical practices. The registration and licensing regime creates barriers to entry, protects incumbent providers from competition, and wastes resources on bureaucratic paperwork. Unseen consequences include reduced access to necessary pain medication, stifled medical innovation, and the criminalization of patients and healthcare providers. The federal government lacks legitimate authority to regulate intrastate drug activities; such matters properly belong to states and local medical boards. Even provisions that appear to reduce burden merely mitigate harms of an otherwise illegitimate and destructive prohibition regime.

Establishes procedures for dispensing controlled substances by prescription, requiring practitioner authorization, legitimate medical purpose, proper documentation, and pharmacist responsibility to prevent diversion.

Creates a massive regulatory burden on healthcare that drives up costs, restricts patient access, and enables government control over medical decisions. The compliance costs and paperwork requirements harm patients while failing to stop determined drug diversion.

Regulation mandates prominent schedule identification symbols on all controlled substance containers, requires tamper-evident seals on Schedule I-II and certain Schedule III-IV substances, and imposes IUPAC nomenclature labeling for anabolic steroids with exemptions for FDA-approved products and research.

Deletion would eliminate uniform visual identification of dangerous drugs, increasing prescription errors and diversion risks; private standards would be inconsistent and inadequate for law enforcement, creating public safety hazards that outweigh minimal compliance costs.